Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wallemacq

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Transplantation|May 24, 2008
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcomeMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|June 9, 2016
Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot studyMartine De Meyer, Vincent Haufroid, Nada Kanaan, et al.
Clinical Pharmacokinetics|May 31, 2002
Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?Michel Mourad, Pierre Wallemacq, Josiane König, et al.
Respiratory Research|October 27, 2006
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis miceRachida Legssyer, François Huaux, Jean Lebacq, et al.
BMC Geriatrics|June 23, 2010
The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in BelgiumBert Vaes, Agnes Pasquet, Pierre Wallemacq, et al.
International Journal of Antimicrobial Agents|April 15, 2011
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapyFabio Silvio Taccone, Daniel de Backer, Pierre-François Laterre, et al.
International Journal of Cardiology|May 19, 2015
General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL studyMiek Smeets, Jan Degryse, Bert Aertgeerts, et al.
Therapeutic Drug Monitoring|August 21, 2015
Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive DrugsUwe Christians, Alexander A Vinks, Loralie J Langman, et al.
Clinical Biochemistry|July 11, 2014
Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?Antoine Buemi, Flora Musuamba, Stephan Frederic, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Transplantation|May 24, 2008
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcomeMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|June 9, 2016
Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot studyMartine De Meyer, Vincent Haufroid, Nada Kanaan, et al.
Clinical Pharmacokinetics|May 31, 2002
Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?Michel Mourad, Pierre Wallemacq, Josiane König, et al.
Respiratory Research|October 27, 2006
Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis miceRachida Legssyer, François Huaux, Jean Lebacq, et al.
BMC Geriatrics|June 23, 2010
The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in BelgiumBert Vaes, Agnes Pasquet, Pierre Wallemacq, et al.
International Journal of Antimicrobial Agents|April 15, 2011
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapyFabio Silvio Taccone, Daniel de Backer, Pierre-François Laterre, et al.
International Journal of Cardiology|May 19, 2015
General practitioners' judgement of chronic heart failure in the oldest old: Insights from the BELFRAIL studyMiek Smeets, Jan Degryse, Bert Aertgeerts, et al.
Therapeutic Drug Monitoring|August 21, 2015
Impact of Laboratory Practices on Interlaboratory Variability in Therapeutic Drug Monitoring of Immunosuppressive DrugsUwe Christians, Alexander A Vinks, Loralie J Langman, et al.
Clinical Biochemistry|July 11, 2014
Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?Antoine Buemi, Flora Musuamba, Stephan Frederic, et al.
Pageof 14